Transcriptomics

Dataset Information

0

RNA Sequencing of HCC cells after lenvatinib, gefitinib, and combination treatment


ABSTRACT: Using a kinome-centred CRISPR/Cas9 genetic screen, we identify here that inhibition of the epidermal growth factor receptor (EGFR) is synthetic lethal with lenvatinib in liver cancer cells. We found that the combination of the EGFR inhibitor gefitinib and lenvatinib displays potent anti-proliferative effect in HCC cell lines that express EGFR in vitro and of xenografted HCC cell lines or patient-derived HCC tumours in mice. Herre, we analyzed the different transcriptome profiling of HCC cells treated with DMSO, lenvatinib, gefitinib, and lenvatinib plus gefitinib by RNA-sequencing.

ORGANISM(S): Homo sapiens

PROVIDER: GSE157905 | GEO | 2021/07/22

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA663315 | ENA
2024-08-07 | GSE273819 | GEO
2023-09-29 | PXD038152 | Pride
2018-02-21 | GSE110815 | GEO
2023-08-08 | GSE223201 | GEO
2019-12-31 | GSE123066 | GEO
2022-03-23 | GSE186191 | GEO
2015-05-16 | GSE68954 | GEO
2010-03-23 | E-GEOD-20854 | biostudies-arrayexpress
2015-05-16 | E-GEOD-68954 | biostudies-arrayexpress